[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) 

# Risk: __Lack of effective pharmaceutical response__ (PBN__Risk_1602)

## Property: has_RiskOwner

* [none](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_629.md)

## Property: has_RiskName

Delayed response and increased mortality rates

## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

## Property: has_RiskTechnology

* [vaccine development technology](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_917.md)
* [drug resistance surveillance technology](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_918.md)

## Property: has_RiskISO_Purpose

* [Resilience](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_2.md)

## Property: has_RiskDescription

Ineffective vaccines and long development time for new vaccines and antibiotics

## Property: has_RiskSubject

* [general population](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_9.md)
* [healthcare systems](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_193.md)

## Property: has_RiskMitigation

* [Improve surveillance for drug resistance, invest in vaccine development infrastructure](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2137.md)

## Property: has_RiskISO_Impact

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Property: has_RiskGBN

* [No](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_0.md)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskSource

* [kumar_role_2021](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_140.md)

